Jennifer is an accomplished professional with 25+ years of clinical research management and technology implementation experience. Jennifer has proven success with strategic planning, project management, data management, quality and risk based systems, and resource planning in many therapeutic areas. Jennifer is a passionate advocate for eSource, Clinical Data Standards, Clinical Data Sciences, Direct-to-Patient technologies and Direct Data Capture. Jennifer is a past Board Member and Secretary of the Society of Clinical Data Management (SCDM) 2015-2020 and currently heads the Data & Analytics group at THREAD.

Executive intrapreneur turned digital health entrepreneur, my career includes 18+ years leading global drug development, clinical research and decentralized trials for life science organizations.

As CEO of THREAD, I lead our efforts to change the way clinical research is conducted focused on decentralized approaches, enabling the use of our one platform for conducting modern research studies and leading partnerships with our customers. After launching and growing THREAD, we were acquired in 2019 by JLL Partners and Water Street with strategic investment for continued growth and focus on accelerating drug development for our customers.

Named one of the Top 100 Influencers in Digital Health, I also provide expertise and execution experience in digital health, clinical trials and decentralized, remote, virtual, community-based clinical research.

I enjoy being a keynote speaker at global industry events, guest lecturer at Duke University on digital health/innovation/entrepreneurship and a published author featured in various conferences, journals, articles and media outlets.

Andy Iverson is the Clinical Outcomes Solutions lead on the Evidence Optimization Center of Expertise team at Medtronic. In this role he functions as a subject matter expert and project team leader for initiatives related to artificial intelligence, decentralized clinical trials, and interoperability. His career includes 10+ years working with provider and payer systems and data. Andy serves as the Co-Chair of HL7s Biomedical Research and Regulation workgroup and is on the Operations Committee of the HL7 Vulcan FHIR Accelerator. He received a BA in Healthcare Management at Concordia College and an MS in Data Science at Northwestern.

Mr. Berger joined the UBC team in 2003 and has since served in a range of diverse roles leveraging global capabilities in the execution of Real World Evidence generation. In this role, Mr. Berger is functionally responsible the teams that deliver the UBC Late Stage Service offering inclusive of study operations, data management, biostatistics and medical writing. His portfolio includes thought leadership, technology development and data partnerships that drive the UBC RWE offering and enable greater insight into the safety profile and value proposition of medicines. Mr. Berger has been leading the operational delivery of interventional & observational research initiatives for 16 years and leverages this experience in the design and execution of modernized approaches to data acquisition and stakeholder engagement. Mr. Berger received his Bachelor’s degree from the University of Kansas, holds the Project Management Professional credential and Six Sigma Green Belt certificate.